The question of WGS’s clinical utility remains unanswered.

May 01, 2021

Florian Battke¹, Björn Schulte², Martin Schulze², Saskia Biskup^{3 4}

Abstract

No abstract available

References
Authors

View this paper on NCBI

View our Panel Diagnostics

CeGaT GmbH, Tübingen, Germany.
Praxis für Humangenetik, Tübingen, Germany.
CeGaT GmbH, Tübingen, Germany. saskia.biskup@cegat.de.
Praxis für Humangenetik, Tübingen, Germany. saskia.biskup@cegat.de.

If you want to stay up to date and informed about new topics around CeGaT, sign up for our newsletter!

Subscribe to Newsletter

Genetic Diagnostics

Research & Pharma Solutions

About Us

CeGaT is a provider of genetic diagnostics and NGS services.
The company is based in Tübingen, Germany and is accredited according to CAP, CLIA, DIN EN ISO 15189 and DIN EN ISO 17025

Terms & Conditions | Privacy Policy | Imprint

Genetic Counseling

Prevention

Family Planning

Prenatal Diagnostics

Rare Diseases

Tumor Diseases

Single Gene & Segregation Analysis

Diagnostic Methods

General Information

Sequencing Services

Epigenomics

Microbiome Analysis

Translational Oncology

Immunology

Pharma Solutions

Knowledge Center

News & Publications

Press Area

Webinars

Events

Career

Our History

Our Values

Our Team

Our Accreditations & Awards

Our Partners

Contact

The question of WGS’s clinical utility remains unanswered.

Abstract

References

Authors